RGACX
Price
$84.07
Change
-$0.44 (-0.52%)
Updated
Jun 22 closing price
Net Assets
360.63B
VAPPX
Price
$24.00
Change
-$0.12 (-0.50%)
Updated
Jun 22 closing price
Net Assets
447.43M
Interact to see
Advertisement

RGACX vs VAPPX

RGACX vs VAPPX Comparison Chart in %
View a ticker or compare two or three
VS
RGACX vs. VAPPX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGACX is a Hold and VAPPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 361B vs. VAPPX (447M). RGACX (0.00) and VAPPX (0.00) have matching dividends . RGACX was incepted earlier than VAPPX: RGACX (24 years) vs VAPPX (28 years). RGACX (0.93) is less costly to investors than VAPPX (0.73). VAPPX is a more actively managed with annual turnover of: 52.00 vs. RGACX (32.00). VAPPX has a lower initial minimum investment than RGACX: VAPPX (0) vs RGACX (250). VAPPX annual gain was more profitable for investors over the last year : 17.54 vs. RGACX (7.94). RGACX return over 5 years is better than : 13.23 vs. VAPPX (7.86).
RGACXVAPPXRGACX / VAPPX
Total Expense Ratio0.930.73127%
Annual Report Gross Expense Ratio0.930.73127%
Fund Existence24 years28 years-
Gain YTD6.1851.259491%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets361B447M80,761%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.9417.5445%
Returns for 3 years43.0556.7276%
Returns for 5 years13.237.86168%
Returns for 10 years107.9762.85172%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CANF3.060.08
+2.68%
Can-Fite Biopharma Ltd
CBLL18.170.14
+0.78%
CERIBELL INC
PNBK1.07N/A
N/A
Patriot National Bancorp
TTAM18.21-0.16
-0.87%
Titan America SA
DOW30.79-0.94
-2.96%
Dow